

In October the National Association of ACOs (NAACOS) and the Institute for Accountable Care published research showing that spending on skin substitute products for wound care is projected to reach $15.4 billion by the end of 2025, a 55% increase over 2024 spending. In response to outcry from NAACOS members and other organizations and a New York Times investigation, the Centers for Medicare & Medicaid Services (CMS) has finalized new rules for skin substitutes, with major changes set to take effect on Jan. 1, 2026.
Will Robinson, senior vice president of accountable care at HarmonyCares, recently co-authored a piece in Health Affairs exploring how ACOs can play a pivotal role in stemming fraud, waste and abuse in wound care. He gave an impassioned talk about the subject at the recent NAACOS conference and spoke to Healthcare Innovation on the topic in depth this week.
Troy, Mich.-based HarmonyCares is a provider of home-based primary care services for complex patients and it participates in both the Medicare Shared Savings Program and ACO REACH. I interviewed Michael Millie, M.D., M.B.A., the company’s chief medical officer, in September 2024.